[1] |
ZHANG Zhihua, CHANG Taihao, LUO Fei, WANG Yashen, LI Jian.
Efficacy and safety of simultaneous prostate biopsy combined with PVP in the treatment of elderly, high-risk and suspected prostate cancer patients
[J]. Tianjin Medical Journal, 2024, 52(9): 959-962.
|
[2] |
XIAO Xiaoli, XIE Yao, LONG Zhi.
Changes and clinical significance of serum miR-155 and miR-205-5p expression levels in patients with hepatitis C virus infection
[J]. Tianjin Medical Journal, 2024, 52(9): 967-970.
|
[3] |
MAN Yi, XU Ya, HE Xiancheng, SONG Shaofeng, LIU Aiguo.
Relationship between expression levels of EGFR, Ki-67, P53 and CTC and the prognosis of triple negative breast cancer
[J]. Tianjin Medical Journal, 2024, 52(8): 862-867.
|
[4] |
ZHANG Guohua, ZHANG Lingling, GAO Lan, LUO Junli, SHEN Yawen, LIU Lei, WANG Yuhua.
Clinical analysis of 16 cases of connective tissue disease-associated interstitial lung disease complicated with lung cancer
[J]. Tianjin Medical Journal, 2024, 52(7): 687-690.
|
[5] |
ZHU Gangming, DONG Yongde, ZHU Ruiting, TAN Yuanman, TAO Juan, LIU Xiao, CHEN Decheng, YANG Gai.
The value of magnetic resonance relaxation time quantitative imaging in predicting molecular subtypes of invasive ductal carcinoma
[J]. Tianjin Medical Journal, 2024, 52(7): 770-774.
|
[6] |
HUO Jingchen, WANG Yue, LI Hua, QIU Rong, SU Jingwei, WANG Zhuofan, YANG Jie.
Predictive value of systemic immune inflammation index (SII) on long-term survival of patients with stage III squamous lung cancer treated with radical radiotherapy
[J]. Tianjin Medical Journal, 2024, 52(6): 634-638.
|
[7] |
CHEN Zhiyan, WU Qiuyuan, DENG Yuhua, ZHOU Dan.
Status and application of organoid technology in breast cancer research
[J]. Tianjin Medical Journal, 2024, 52(6): 668-672.
|
[8] |
LIU Danyang, LI Yongtao, ZHANG Haiyan, LI Lin, LIU Yang, SHEN Lei.
Effect of breast cancer cell conditioned medium on biological behavior of bone marrow mesenchymal stem cells
[J]. Tianjin Medical Journal, 2024, 52(5): 454-458.
|
[9] |
MIAO Chunbo, XU Yingchun, CHANG Yifang.
Phlorizin allevistes oxidative stress and apoptosis of rat cardiac myocytes H9C2 induced by hypoxia/reoxygenation by down-regulating miR-125a-5p
[J]. Tianjin Medical Journal, 2024, 52(12): 1233-1238.
|
[10] |
LU Xinyi, DU Weipo, LI Jinggang, GUO Fangfang, ZHANG Xiaolei, LIU Jing.
Correlation between serum miR-193a-3p, ATF5 levels and chemotherapy efficacy in patients with triple negative breast cancer
[J]. Tianjin Medical Journal, 2024, 52(12): 1313-1316.
|
[11] |
XIE Haoran, LI Yihao, LIU Cheng, XIA Yuting, QIU Shenglei, XIONG Bin, FENG Qizhen.
Research of predictive factors of axillary lymph node metastasis in breast cancer under the context of DIP payment of medical insurance
[J]. Tianjin Medical Journal, 2024, 52(11): 1193-1196.
|
[12] |
WU Meina, DAI Weizheng, PAN Yudun, FU Maolin, CHEN Xiaoyu.
Clinical value of routine electroencephalogram combined with serum miR-146a and miR-129-5p levels in diagnosis of drug-resistant epilepsy patients
[J]. Tianjin Medical Journal, 2024, 52(11): 1207-1210.
|
[13] |
DENG Qianbao, ZHANG Zhongxia, WANG Ru, XU Lin, LUO Shu.
Efficacy analysis of a preeclampsia risk prediction model based on exosomal multiple miRNA expression levels
[J]. Tianjin Medical Journal, 2024, 52(1): 91-96.
|
[14] |
WU Haixiao, MA Wenjuan, LI Zhijun, ZHANG Chao.
Relationship between pectoralis muscle index and prognosis of breast cancer patients with bone metastases based on radiomics
[J]. Tianjin Medical Journal, 2023, 51(9): 1007-1010.
|
[15] |
HOU Yongbo, YU Junma, ZHU Haijuan.
New research progress of exosomes in the treatment of myocardial infarction
[J]. Tianjin Medical Journal, 2023, 51(9): 1016-1019.
|